Tekmira Pharmaceuticals Corporation (Nasdaq: TKMR) announced today that preclinical data demonstrating potent anti-viral activity of TKM-Marburg were presented at DIA/FDA ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE